Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsBenjamin Dehay, Wassilios G. Meissner, Gregory A. Petsko et al.|The Lancet Neurology|2015Cited by 508
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's diseaseMatthieu F. Bastide, Erwan Bézard, Wassilios G. Meissner et al.|Progress in Neurobiology|2015Cited by 472
Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in miceBenjamı́n Caballero, Ana María Cuervo, Mathieu Bourdenx et al.|Nature Communications|2021Cited by 216
In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seedsNaoto Watamura, Takaomi C. Saido, Martha Foiani et al.|Nature Neuroscience|2024Cited by 44
Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the modelMathieu Bourdenx, Benjamin Dehay|Scientific Reports|2017Cited by 25